Find Your Funding Opportunity
NIAID Clinical Trial Implementation Cooperative Agreement
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
02-25-2026 | N/A | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Opportunity Type Discretionary
-
CFDA
93.855 -- Allergy and Infectious Diseases Research
Description
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the NIAID Clinical Trial Implementation Cooperative Agreements. This program encourages cooperative agreement applications for implementation of investigator-initiated, milestone driven, high-risk clinical trials including mechanistic studies associated with these clinical trials. Due to thisfocus, the program encompasses both basic and clinical research. This program includes support for the conduct, completion, and analysis of the clinical trial. Additional activities supported are related to the conduct of the clinical trial including training of study personnel; enrollment and recruitment of study subjects; data collection, clinical data management and quality control; investigational product costs; laboratory work and data analyses; study management and oversight; post-trial activities; and regulatory activities and site monitoring. Grant authorities that allow NIAID to forecast this opportunity are as follows:Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Key Date(s)
- June 27, 2025: Last Updated Date
- June 27, 2025: Forecasted Date
- December 05, 2025: Estimated Post Date
- February 25, 2026: Estimated Application Due Date
- December 01, 2026: Estimated Project Start Date
- December 01, 2026: Estimated Award Date